These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
595 related articles for article (PubMed ID: 21733175)
1. Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ). Bachstetter AD; Xing B; de Almeida L; Dimayuga ER; Watterson DM; Van Eldik LJ J Neuroinflammation; 2011 Jul; 8():79. PubMed ID: 21733175 [TBL] [Abstract][Full Text] [Related]
2. Microglial p38α MAPK is critical for LPS-induced neuron degeneration, through a mechanism involving TNFα. Xing B; Bachstetter AD; Van Eldik LJ Mol Neurodegener; 2011 Dec; 6():84. PubMed ID: 22185458 [TBL] [Abstract][Full Text] [Related]
3. A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model. Munoz L; Ralay Ranaivo H; Roy SM; Hu W; Craft JM; McNamara LK; Chico LW; Van Eldik LJ; Watterson DM J Neuroinflammation; 2007 Sep; 4():21. PubMed ID: 17784957 [TBL] [Abstract][Full Text] [Related]
4. Deficiency in p38β MAPK fails to inhibit cytokine production or protect neurons against inflammatory insult in in vitro and in vivo mouse models. Xing B; Bachstetter AD; Van Eldik LJ PLoS One; 2013; 8(2):e56852. PubMed ID: 23457629 [TBL] [Abstract][Full Text] [Related]
5. Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways. Dai JN; Zong Y; Zhong LM; Li YM; Zhang W; Bian LG; Ai QL; Liu YD; Sun J; Lu D PLoS One; 2011; 6(7):e21891. PubMed ID: 21765922 [TBL] [Abstract][Full Text] [Related]
6. The p38alpha mitogen-activated protein kinase limits the CNS proinflammatory cytokine response to systemic lipopolysaccharide, potentially through an IL-10 dependent mechanism. Bachstetter AD; Xing B; Van Eldik LJ J Neuroinflammation; 2014 Oct; 11():175. PubMed ID: 25297465 [TBL] [Abstract][Full Text] [Related]
8. MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease. Culbert AA; Skaper SD; Howlett DR; Evans NA; Facci L; Soden PE; Seymour ZM; Guillot F; Gaestel M; Richardson JC J Biol Chem; 2006 Aug; 281(33):23658-67. PubMed ID: 16774924 [TBL] [Abstract][Full Text] [Related]
9. Cross talk between the Akt and p38α pathways in macrophages downstream of Toll-like receptor signaling. McGuire VA; Gray A; Monk CE; Santos SG; Lee K; Aubareda A; Crowe J; Ronkina N; Schwermann J; Batty IH; Leslie NR; Dean JL; O'Keefe SJ; Boothby M; Gaestel M; Arthur JS Mol Cell Biol; 2013 Nov; 33(21):4152-65. PubMed ID: 23979601 [TBL] [Abstract][Full Text] [Related]
10. LRP1 modulates the microglial immune response via regulation of JNK and NF-κB signaling pathways. Yang L; Liu CC; Zheng H; Kanekiyo T; Atagi Y; Jia L; Wang D; N'songo A; Can D; Xu H; Chen XF; Bu G J Neuroinflammation; 2016 Dec; 13(1):304. PubMed ID: 27931217 [TBL] [Abstract][Full Text] [Related]
11. Glimepiride reduces CD14 expression and cytokine secretion from macrophages. Ingham V; Williams A; Bate C J Neuroinflammation; 2014 Jun; 11():115. PubMed ID: 24952384 [TBL] [Abstract][Full Text] [Related]
12. p38α-MAPK-deficient myeloid cells ameliorate symptoms and pathology of APP-transgenic Alzheimer's disease mice. Luo Q; Schnöder L; Hao W; Litzenburger K; Decker Y; Tomic I; Menger MD; Liu Y; Fassbender K Aging Cell; 2022 Aug; 21(8):e13679. PubMed ID: 35909315 [TBL] [Abstract][Full Text] [Related]
13. The p38α MAPK regulates microglial responsiveness to diffuse traumatic brain injury. Bachstetter AD; Rowe RK; Kaneko M; Goulding D; Lifshitz J; Van Eldik LJ J Neurosci; 2013 Apr; 33(14):6143-53. PubMed ID: 23554495 [TBL] [Abstract][Full Text] [Related]
14. Glia as a therapeutic target: selective suppression of human amyloid-beta-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration. Ralay Ranaivo H; Craft JM; Hu W; Guo L; Wing LK; Van Eldik LJ; Watterson DM J Neurosci; 2006 Jan; 26(2):662-70. PubMed ID: 16407564 [TBL] [Abstract][Full Text] [Related]
15. Target engagement analysis and link to pharmacodynamic endpoint for a novel class of CNS-penetrant and efficacious p38α MAPK inhibitors. Bachstetter AD; Watterson DM; Van Eldik LJ J Neuroimmune Pharmacol; 2014 Sep; 9(4):454-60. PubMed ID: 24789302 [TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells. Zhong LM; Zong Y; Sun L; Guo JZ; Zhang W; He Y; Song R; Wang WM; Xiao CJ; Lu D PLoS One; 2012; 7(2):e32195. PubMed ID: 22363816 [TBL] [Abstract][Full Text] [Related]
18. Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology. Maphis N; Jiang S; Xu G; Kokiko-Cochran ON; Roy SM; Van Eldik LJ; Watterson DM; Lamb BT; Bhaskar K Alzheimers Res Ther; 2016 Dec; 8(1):54. PubMed ID: 27974048 [TBL] [Abstract][Full Text] [Related]
19. CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase. Tan J; Town T; Mori T; Wu Y; Saxe M; Crawford F; Mullan M J Neurosci; 2000 Oct; 20(20):7587-94. PubMed ID: 11027218 [TBL] [Abstract][Full Text] [Related]
20. Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia. Nayak D; Huo Y; Kwang WX; Pushparaj PN; Kumar SD; Ling EA; Dheen ST Neuroscience; 2010 Mar; 166(1):132-44. PubMed ID: 20036321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]